FIP in Cats: Wet and Dry Forms, the GS-441524 Market in India, and What Recovery Actually Means

Signs of Feline infectious peritonitis

The 10 signs to watch for are listed below. Any one of them is a reason to consult your nearby vet; none of them is a diagnosis.

• A fever that comes and goes and does not answer antibiotics
• Eating less, losing weight, or a kitten that stops growing
• Lethargy, hiding, no interest in play
• A swollen, pot-bellied abdomen that feels fluid-filled
• Fast or laboured breathing, or breathing with the mouth open
• Yellow gums, yellow eyes, or dark yellow to brown urine
• Cloudy eyes, a red eye, or two pupils of different sizes
• Wobbly walking, head tilt, tremors or seizures
• Diarrhoea or vomiting that keeps returning
• Pale gums and weakness from anaemia

Breeds on this site that document this condition

Every card below reports the same 2006 study, because it is the only one that ranked individual cat breeds for FIP with a denominator on each. It counted 11,535 cats of known breed at one American veterinary teaching hospital over 16 years, and the breed samples inside it are tiny. Read direction, not precision.

What FIP in cats is, and how an indoor cat gets it

FIP in cats is a disease that develops inside one cat from a virus almost every cat meets. The starting point is feline coronavirus, a gut virus that usually causes nothing at all, or a brief bout of diarrhoea, and that spreads between cats in faeces. In roughly 10 percent of infected cats one or more mutations change the virus so that it infects white blood cells and travels through the body, and that mutated form is what causes feline infectious peritonitis. The cat did not catch FIP from another cat. It caught a common coronavirus and its own copy of that virus changed.

That single fact answers the question Google India asks most often about this disease. An indoor cat with no outdoor life gets FIP because it met feline coronavirus at some earlier point, usually before it came home. The commonest route is a queen passing the virus to her kittens at around five to eight weeks old, and it also moves between adult cats through faeces. Contact is efficient to the point of near certainty. Nearly 100 percent of cats that come into contact with the enteric coronavirus in the faeces of a shedding cat become infected.

The numbers on exposure are worth reading before anyone panics about a positive test. In serum from 1,117 UK cats collected between 2020 and 2023, overall feline coronavirus seroprevalence was 59.5 percent, and neutralising antibody against the type II virus was found in 13.6 percent; worldwide seroprevalence for this virus ranges between 4 and 95 percent depending on the population sampled. Up to 80 percent and more of cats in multi-cat households carry serum antibodies against feline coronavirus, and most of them never develop FIP.

Wet FIP and dry FIP, and why the labels blur

The two forms are named for fluid. Wet or effusive FIP produces fluid in the abdomen or the chest, so the cat looks pot-bellied or struggles to breathe; dry or non-effusive FIP produces inflammatory lesions, called pyogranulomas, inside organs including the eyes and the brain, so the signs are slower and stranger. The split is driven by the cat's own immune response rather than by a different virus.

Do not treat the two as separate diseases. International Cat Care's caregiver guide is blunt that many cats with FIP show signs of both types when they are investigated thoroughly, and Cornell notes that an effusive case can evolve into a non-effusive one and the reverse. In the 68 Cypriot cases reported by 22 clinics during that island's outbreak, the two forms were spread across the caseload and a third of cats showed neurological or mental signs on top.

That last row is the reason this page keeps the two forms apart. In the systematic review that pooled 11 studies and 650 treated cats, wet FIP had a success rate of about 77.7 percent against an overall 84.6 percent, cats with ocular signs alone did as well as uncomplicated cases at about 90 percent, cats with neurological FIP reached about 68 percent, and the few with both neurological and ocular signs came in at about 43 percent.

Which cats develop it, with the denominators

Young, pedigree and crowded is the profile. About 70 percent of cases are diagnosed in cats under a year and a half old and 50 percent in cats under seven months. In the 11,535-cat American hospital series, the median age at last evaluation was 0.96 years and 67 percent of affected cats were under two. Sexually intact cats made up 45.6 percent of the FIP group against 15.8 percent of the general hospital population, a difference the authors found highly significant.

Cats living at density carry more risk for a mechanical reason rather than a mysterious one. More cats sharing more litter trays means more coronavirus circulating, and Cornell recommends housing cats at or below three per room to hold the stress and the viral load down. International Cat Care adds recent stress to the list, naming a move to a new home or even a routine clinic visit as recognised triggers.

The genetics are real but partial. UC Davis chose Birman cats for a genome-wide association study of FIP susceptibility precisely because the breed is highly inbred and suffers a high incidence of the disease, genotyping DNA from 38 Birmans that died of FIP against 161 healthy Birmans from breeders in Denmark and the USA on a 63,000-marker array. Susceptibility looks polygenic rather than a single switch, which is why no DNA test for FIP risk exists to buy. If you are choosing a kitten, our guide to adopting a cat in India covers what to ask a breeder or a shelter before money changes hands.

The first signs, and the day to stop waiting

The first signs of FIP in cats are boring, which is exactly what makes them dangerous. A cat goes quiet, eats less, loses weight and runs a fever that comes and goes and does not respond to antibiotics. Every one of those signs is nonspecific, and nothing in that list points at a coronavirus. In the 68 Cypriot cases, the most frequently reported signs were anorexia at 60.3 percent and weight loss at 54.4 percent, both entirely non-specific, and in 243 Swiss cats treated for FIP the presenting complaints were hyporexia or anorexia in 70 percent (166 of 236), weight loss in 63 percent (149 of 236) and lethargy in 59 percent (140 of 236).

A kitten that stops growing is the version of this an owner is most likely to miss. International Cat Care lists reduced growth against littermates as an early sign in its own right, alongside eating less and losing weight. If you have a young cat in the house, our kitten care guide for India covers the weight and growth milestones to measure against.

Then the specific signs arrive, and they arrive by form. Fluid in the abdomen gives a pot-bellied look; fluid in the chest makes breathing fast or difficult; yellow gums and dark urine follow a rise in bilirubin; and the eyes can go cloudy or red with pupils of different sizes. Neurological signs run from a wobbly gait and head tilt to tremors and seizures. Those mental and neurological presentations made up 35.3 percent of the Cypriot caseload, a share the authors read as evidence that the recombinant virus circulating there favoured the nervous system.

What the blood work shows before anyone says the word FIP

A routine blood panel often carries the first real clue. The classic pattern is a high total protein driven by high globulins, with albumin normal or low, anaemia, altered white cell counts and sometimes high bilirubin. Put the two protein numbers together and you get the albumin to globulin ratio, the single cheapest number that moves the needle on this disease.

The Swiss and Cypriot series agree on how often it is abnormal. Among 243 Swiss cats, hyperglobulinaemia was present in 80 percent (179 of 223), an A:G ratio below 0.4 in 53 percent (120 of 225), anaemia in 55 percent (124 of 224) and a raised serum amyloid A in 78 percent (51 of 65). In the Cypriot outbreak cases, an A:G ratio below 0.8 was seen in 86.8 percent of the cats tested. Several cut-offs are published, broadly below 0.4 to raise suspicion and above 0.6 to 0.8 to lower it, and the reviewers stress that the ratio must be read alongside signalment, history and other tests rather than alone.

Some cats with FIP have entirely normal blood tests, which International Cat Care says plainly. A normal panel does not clear a cat, and that is the second half of the same sentence.

Why an FCoV antibody titre does not diagnose FIP, and how a diagnosis is actually reached

To diagnose FIP, a veterinarian assembles a picture rather than runs one test, because no single test confirms the disease. International Cat Care describes it as a jigsaw: clinical signs and examination first, then blood tests and imaging to raise or lower suspicion and to rule out the diseases that mimic FIP, then sampling of any abnormal fluid or organ, and finally the piece that turns a suspicion into a confirmation, which is finding coronavirus inside that fluid or tissue. The antibody titre an Indian owner is most likely to be offered sits outside that sequence.

The reliability of FIP blood tests is the question VCA's owner page puts in a heading of its own, and it is the right question to start with. A feline coronavirus antibody titre tells you the cat has met the virus. It does not tell you the cat has FIP. Cornell states that antibody levels cannot distinguish exposure to the harmless enteric coronavirus from the mutated FIP virus, and that a positive result means only prior exposure to coronavirus. International Cat Care lists coronavirus serology among the tests that are less helpful for diagnosing FIP, for the simple reason that the virus is so common that many cats test positive without having the disease.

The arithmetic behind that warning is stark. If up to 80 percent and more of cats in a multi-cat household carry antibodies and 59.5 percent of 1,117 UK cats were seropositive, then a positive titre in a sick cat in a crowded Indian home is close to the base rate. Cornell adds the mirror-image trap, that a healthy cat with a high titre is not more likely to develop FIP or to be a carrier than a cat with a low one, while a cat whose immune system is exhausted by advanced FIP may fail to produce enough antibody and test falsely negative.

The measured performance confirms it. In the largest series tabulated in the standard diagnostic review, an immunofluorescence antibody test on serum, judged against histopathology in 97 cats with FIP and 245 control cats with other diseases, had a sensitivity of 85 percent and a specificity of only 57 percent. Across the studies reviewed, serum antibody sensitivity ranged from 28 to 100 percent and specificity from 25 to 98 percent. A test that misclassifies roughly four in ten non-FIP cats is not a diagnosis, and a cat should not be put on a twelve-week course of antivirals on the strength of one.

The tests that do carry weight, in the order they are used

Three things change a diagnosis from likely to confirmed, and all three need a sample from where the disease is. A fluid tap for analysis comes first, because the fluid in FIP is characteristically yellow, sticky and high in protein. Then RT-PCR on that fluid or on affected tissue, which detects the viral genetic material directly and which International Cat Care says is not recommended for diagnosis on blood or faeces alone. Then immunohistochemistry, which stains the virus inside inflammatory cells under the microscope. Immunohistochemistry on tissue has a sensitivity of 97 to 100 percent in cats with histopathologically confirmed FIP and a specificity of up to 100 percent.

One cheap test deserves more attention in India than it gets anywhere else. The Rivalta test is performed on effusion in the consulting room with no automated analyser at all, and the reviewers state that it should be included in the diagnostic protocol for every cat with an effusion, adding specifically that where financial concerns limit how many tests can be run it can at least exclude FIP with a satisfying negative predictive value. Its sensitivity for excluding FIP runs 91 to 100 percent while its specificity is only 66 to 81 percent, so a negative result is informative and a positive one simply means keep going.

The Indian charity ranking fifth on the treatment query gets this right without showing its working. FSGI's own page carries the heading 'Don't accept a blood PCR as proof';, and the 7 percent sensitivity figure above is the evidence for that instruction which the page itself does not give.

Finally, the honest position on treating before the picture is complete. International Cat Care accepts that a treatment trial is sometimes unavoidable, when a cat is too unwell to sample safely or the results are inconclusive, and sets a condition: run at least basic blood tests, check for and sample any fluid, and if the cat has not improved significantly within a week, go back and look for a different disease. That condition is what separates a treatment trial from a guess. In the Swiss primary-care series, only 28 percent of the 243 cats had an FCoV PCR run at all and only 28 percent had a serum titre, which the authors read as a decision to treat resting on a presumptive diagnosis with minimal testing.

What treatment achieves, what it does not, and the honest answer on cure

To treat FIP, a veterinarian gives an antiviral nucleoside analogue by mouth or by injection, usually for 12 weeks, and monitors the cat's weight, blood work and fluid through the course. The drugs in use are GS-441524, remdesivir, EIDD-1931 and molnupiravir, plus the protease inhibitors GC376 and Paxlovid, and which of them a country's veterinarians can legally reach varies enormously. This page names the molecules and never the amounts, because how much any cat receives is a calculation the treating veterinarian makes for that animal, adjusted as the cat gains weight.

Start with what the pooled evidence shows, because it is the number every seller quotes and almost nobody sources. A 2025 PRISMA systematic review pooled 11 studies covering 650 FIP cases treated with GS-441524, alone or in combination, and reported an overall treatment success rate of 84.6 percent, which it states as 550 of 650 cats surviving in remission. Against the historical picture of near-total mortality, that is the largest change in feline medicine in a generation. A disease that was uniformly fatal is now a treatable one, and the prognosis for a cat that is diagnosed correctly and treated fully is survival rather than death.

The averages hide a spread that matters to the owner of a particular cat. Of those 650 cases, 169 (26.0 percent) had what the reviewers call complicated FIP, meaning neurological, ocular or renal involvement, and in that group combined success fell to about 74.5 percent against about 84 percent overall, a difference significant at p = 0.0076. Inside the complicated group, ocular signs alone did no harm at all at about 90 percent success, neurological FIP came in at about 68 percent, and the seven cats with both neurological and ocular signs at about 43 percent.

Can a cat with FIP recover? Read the denominators, not the headline

Yes, most treated cats recover and are considered cured, and the best single estimate is the 84.6 percent of 650 pooled cases that survived in remission. International Cat Care puts the same finding in caregiver language, that research shows around 85 percent of cats respond well, appear to be cured and go on to live normal lives. Those two figures come from different routes to the same place, which is why this page quotes both rather than picking one.

The original trial deserves reading in full rather than as a headline. At UC Davis, 31 cats with naturally occurring FIP were recruited, of which 26 had effusive or dry-to-effusive disease and 5 non-effusive, and cats with severe neurological and ocular FIP were deliberately not recruited. Four of the 31 died or were euthanised within two to five days and a fifth after 26 days; the remaining 26 completed the planned 12 weeks or more; 18 of those 26 stayed healthy after one round while 8 relapsed within 3 to 84 days, and after re-treatment the study ended with 25 long-term survivors, one of which was later euthanised for unrelated heart disease, leaving 24 healthy at publication.

That arithmetic is the reason to ask any seller which denominator its success rate uses. Twenty-four healthy cats out of the 26 that completed treatment is 92 percent; the same 24 cats out of the 31 recruited is 77 percent. BasmiFIP India's storefront prints '92% Success rate' under the label 'UC Davis clinical trial' with no denominator beside it, and the trial it names is the one described above.

How long does a cat live with FIP, treated and untreated

Untreated, the answer is short and every source agrees on it. Once clinical FIP develops, the disease is usually progressive and almost always fatal without antiviral therapy, and the Indian clinic page ranking on this query puts the timescale at days to weeks for the wet form and weeks to months for the dry form.

Treated, the best survival figure with a real denominator comes from the United Kingdom and Australia. 307 cats treated with legally sourced, veterinary-prescribed compounded remdesivir and GS-441524 between 2020 and 2022 were followed, and at the longest follow-up point after the initial treatment period 84.4 percent were alive. The median initial treatment period was 84 days with a range of 1 to 330, and the median longest follow-up was 248 days with a range of 1 to 814, so this is survival measured over months rather than a discharge rate. Cats that achieved a complete response within 30 days of starting were significantly more likely to be alive at the end of the treatment period.

Relapse, which the seller pages mention and do not quantify

Relapse is uncommon, real and measured. In that same 307-cat cohort, 33 cats (10.8 percent) relapsed, 15 of them during the initial treatment period and 18 after it finished. International Cat Care describes relapse as affecting a small proportion of cases, often within a couple of weeks of completing treatment, and says the response should be to review both the diagnosis and the dosing, because many of those cats are then successfully treated.

Two longer-term findings are newer than most pages on this topic and belong here. A 2026 case series from LMU Munich and the University of Zurich reported large-cell lymphoma in 4 of 202 cats (2.0 percent) in a treatment cohort, arising 81 to 595 days after FIP diagnosis and successful treatment with legally sourced oral GS-441524, with no feline coronavirus antigen or high viral load found in the available samples; the authors propose it be considered a possible long-FIP syndrome and call the incidence remarkably high against the general cat population. That is four cats, it is a case series rather than a cohort study, and it is the kind of finding that needs confirming before anyone changes what they do.

Supportive care carries a real share of the outcome and costs money too. Appetite stimulants and anti-sickness drugs for the first days, a feeding tube for some cats, drainage of fluid where it is compromising breathing, and medication for seizures or for the eyes where those are involved. Nutritional supplements are not needed if the cat is eating a complete diet, and International Cat Care states directly that nothing extra is required to protect the liver during antiviral treatment. Our adult cat care guide for India covers the feeding and weighing routine a recovering cat needs.

GS-441524: what the molecule is, where it is legal, and what the Indian SERP is actually selling

GS-441524 is a nucleoside analogue that blocks viral RNA replication, and it is the breakdown product of remdesivir, the drug approved for human COVID-19. It is not a herb, not a supplement and not a veterinary invention. It is a pharmaceutical molecule patented by an American company, and its legal status in any given country is the single most consequential fact an Indian owner needs, because the search results for FIP treatment in India are led by people selling it.

Search Google India for 'fip treatment india' on 23 September 2026 and the first eight organic results contain no veterinary body, no university and no regulator. Position one, position four via a Linktree and position eight are the same Indian storefront; position two is that storefront's Facebook page; positions three and six are a European and a Malaysian seller; position seven is a Philippine commercial write-up. Position nine is a Reddit thread from an Indian owner asking for help paying for the drug. The one Indian veterinary clinic page that ranks anywhere near them, from the Vetic chain, states that antiviral treatment is available in India at specialist clinics and gives no price and no legal position.

The regulatory position in three countries, stated plainly

The United Kingdom has a legal route. Compounding in the UK is not restricted to products holding a marketing authorisation, so a specials manufacturer produces GS-441524 and it is legally available there in tablet form on prescription, while remdesivir is available with no supply problem but restricted to referral practice. The Federation of Veterinarians of Europe and FECAVA published that country table precisely because most European countries have no legal option at all, and they urged policymakers to give EU veterinarians one so that owners stop turning to the illegal market.

The United States has an enforcement position rather than an approval. On 10 May 2024 the FDA's Center for Veterinary Medicine stated that because no FDA-approved drug is available to treat FIP, it does not intend to enforce new animal drug approval requirements against products compounded from GS-441524 when a veterinarian prescribes them for a specific cat, under the conditions in Guidance for Industry #256. The same notice is careful about what that is not, reminding pharmacies, veterinarians and owners that animal drugs compounded from bulk substances are unapproved drugs and are not, in fact, legal, and noting that as of that date no nomination had been received to allow office stock. Cornell records that the drug had been available in Australia and the UK for several years before a compounded oral formulation reached the US, where it requires a veterinary prescription.

The Indian position could not be established from a primary source, and this page says so rather than guessing. The country-by-country access page maintained for FIP veterinarians lists GS-441524 as reachable through veterinary channels in the United States, Canada, Australia, France, Hong Kong, Italy, Portugal, New Zealand, Singapore, South Africa and the United Kingdom, plus Cyprus, the Czech Republic, Finland, Ireland and Sweden by order from the UK compounder; India appears nowhere on that list. India does appear twice on the same page, in the global notes for molnupiravir and for remdesivir, both approved for human use in India, where the page records that it appears veterinarians can access them fairly easily. No Indian regulator's own page stating a position on GS-441524 for cats was found on 23 September 2026, so what this page can honestly report is an absence of any listed veterinary channel, not a positive statement of Indian law. Ask your own veterinarian what they are legally able to prescribe, and ask them to write it down.

What unlicensed product actually contains, assayed

One study has put black-market FIP antivirals through a mass spectrometer, and every Indian owner buying online should know its result. Researchers at Ohio State, UC Davis and the University of Virginia obtained 127 injectable and oral samples from 30 of the most popular brands of unlicensed producer and measured their GS-441524 and remdesivir content by liquid chromatography with tandem mass spectrometry.

• Every product tested did contain GS-441524, which is the finding that cuts against the assumption that these are simply fakes.
• Of 87 injectable formulations, 95 percent contained more drug than the producer advertised, on average 39 percent more.
• The average pH of the injectables was 1.30, far below the physiological range recommended for subcutaneous injection.
• Oral products varied in both directions, with 43 percent containing more than advertised, on average 75 percent more, and 58 percent containing less, on average 39 percent less.
• One injectable and two oral samples also contained remdesivir, which was not what the label said was in them.

The authors' own conclusion is not that owners should stop, it is that the products need regulation and that legal routes to obtain the drug need building. International Cat Care reaches the practical version of the same point, that medication obtained on prescription is correctly labelled, quality tested and guaranteed to contain the stated amount, which is what makes accurate dosing possible, while publications have shown internet-sourced drugs vary enormously in content and quality. That acidic pH is also why a subcutaneous injection of these drugs hurts; injection pain was reported in 47.8 percent of the 307 UK and Australian cats given subcutaneous remdesivir, and International Cat Care advises against the subcutaneous route unless it is the only option available.

Auditing the seller's own claims

A seller's page is a commercial source, not a clinical one, and it is cited here only as evidence of what it itself says and charges. BasmiFIP India's storefront carries four headline numbers: a 92 percent success rate attributed to the UC Davis clinical trial, 100,000 cats treated and supported since 2019, an 84-day protocol, and a 12-month relapse guarantee under which a relapse inside a year gets 50 percent off the next course. Its own FAQ tells owners that stopping early is the most common reason treatment fails and that improvement in the first week is not the finish line, which is sound and matches the veterinary guidance.

Three things about those claims are checkable and worth checking. The 92 percent traces to a trial of 31 recruited cats in which 24 were healthy at publication, so the figure holds against the 26 cats that completed treatment and not against the 31 that started. The 100,000 figure is a company claim with no published basis and is not a clinical outcome of any kind. And the site directs owners to a dosage calculator and a WhatsApp specialist rather than to a veterinarian, while the diagnostic problem described earlier in this page means that a cat put on an 84-day course without fluid analysis or tissue confirmation may not have FIP at all Felten S, Hartmann K. Diagnosis of Feline….

Two studies have measured what happens when owners buy this way, and they are not a horror story. A survey of 393 owners who treated their own cats with unlicensed GS-441524-like drugs found 96.7 percent of cats alive at the time of the survey, 54.0 percent considered cured and another 43.3 percent still inside the 12-week observation period, with 12.7 percent relapsing and 3.3 percent dying despite therapy. Only 8.7 percent of those owners reported any help from their veterinarian in administering the treatment, and the commonest complications were owner-administered injection problems, including vocalisation, pain, struggling and injection-site wounds. A later prospective cohort of 141 owners who completed 12 weeks found treatment shifting from injections to pills, rising veterinary awareness and monitoring, and owners reporting that the human-animal bond suffered during the course.

What FIP costs in India, from rate cards and a storefront

FIP treatment costs an Indian owner in two separate places, and only one of them is published. The diagnostic work-up is priced openly by Indian government veterinary universities, in rupees, on their own websites. The drug is not priced by any Indian institution at all, and the only Indian rupee figures available for it come from a seller's own storefront. This section gives both, labelled for what they are, and every rupee figure below was divided by 84.38 and by 74 before publication to confirm it is a real Indian price rather than a converted dollar list. It exists because the ranking pages do not carry one: the page sitting first on the bare Google India query has a heading literally called Cost under which it says only that the drug is expensive and must be given for a long time.

Bihar Animal Sciences University in Patna prices most of an FIP work-up, and one line item is named for this disease. Its Veterinary Clinical Complex fee tables list a bedside FIP antigen test at Rs 300, the biochemistry panel covering total protein, albumin, globulin and the A:G ratio at Rs 160, serum amyloid A at Rs 1,000, a complete blood count for a cat at Rs 300, fine needle aspiration cytology at Rs 250, histopathology at Rs 500 per specimen, ultrasound at Rs 500, an X-ray at Rs 400 and an outpatient registration for a cat at Rs 200 valid ten days, or Rs 300 for an emergency visit valid five days.

ICAR-IVRI at Izatnagar prices the same work differently and more cheaply. Its Referral Veterinary Polyclinic schedule, with effect from June 2024, lists cytology at Rs 150, fine needle aspiration cytology at Rs 150, histopathology at Rs 150, a lateral flow test for infectious diseases at Rs 500, fluid therapy at Rs 150, a liver function panel at Rs 400 and registration for a dog or cat at Rs 30 in normal hours, rising to Rs 200 after 12:30 PM and Rs 400 after 5 PM or on holidays. Madras Veterinary College's Centralised Clinical Laboratory in Chennai charges Rs 300 per sample for cytology, Rs 600 per sample for a 13-parameter haematology panel and Rs 150 per parameter for serum biochemistry on private samples, dropping to Rs 200 per sample for fine needle aspiration cytology on hospital cases.

What the drug costs, from the storefront that ranks first

No Indian institution prices the antiviral, so the only Indian rupee figures are commercial. BasmiFIP India's injectable listing page, read on 23 September 2026, prices three vials of GS-441524 at Rs 3,590, Rs 4,990 and Rs 5,990, written on the page itself as ₹3,590.00, ₹4,990.00 and ₹5,990.00, each sold individually. Those three figures were put through the conversion test and they read as rupee prices. Divided by 84.38 they give 42.55, 59.14 and 70.99; divided by 74 they give 48.51, 67.43 and 80.95. Only one of those six results lands near a round dollar figure, and all three rupee prices end in 90, which is the shape of an Indian retail price list rather than a dollar list converted at a single rate.

The storefront prints no total course price, and it cannot, because the number of vials depends on the cat's weight and on the form of FIP, which is precisely the calculation a veterinarian should be making rather than a calculator on a sales page Taylor S, Tasker S, Barker E, Gunn-Moore D. Its own FAQ states the protocol runs 84 days without gaps, so an owner should multiply, ask, and budget for the full course before starting.

The dollar figures, reported as dollars and not converted

Three published cost figures exist for this treatment and all three are in United States dollars for United States or international markets. This page reports them as dollars and does not convert them into an Indian price, because a converted foreign price is not an Indian price.

• About USD 200 to 1,200 for a 3 kg cat through a US compounding pharmacy, per the country-by-country access page maintained for FIP veterinarians.
• USD 195, USD 325 and USD 546 for the three pack sizes published by Stokes Pharmacy, the licensed US pharmacy that Cornell named as making a compounded oral formulation available from 1 June 2024, excluding shipping and tax.
• A mean of USD 4,920 paid by 393 owners who sourced unlicensed product themselves and were surveyed in 2021.
• About USD 3,100 on average in a 2024 prospective cohort of 141 owners, a figure the authors note has fallen since 2021.

One line on that US pharmacy page decides the whole question for an Indian reader. Stokes states that it does not currently ship internationally. The legal, quality-assured, prescription route that a US owner can use is closed to an Indian owner by the pharmacy's own shipping policy, which is the practical reason the Indian search results look the way they do. Our guide to pet insurance in India covers whether any Indian policy would meet a bill of this shape, and most exclude pre-existing conditions.

Which cats are at risk, and how small the breed evidence really is

Risk of FIP is driven by age, by living at density and by being entire, and breed sits on top of that rather than replacing it. The evidence for a breed effect comes from essentially one study, and reading it properly is more useful to an Indian buyer than repeating its top line. Over 16 years at a North Carolina veterinary teaching hospital, 11,535 cats of known breed were examined, of which 9,511 were mixed-breed and 2,024 were purebred across 36 varieties, and 60 cats, or 0.52 percent, were diagnosed with FIP.

The purebred effect in that dataset is solid, because it rests on the large groups. FIP prevalence was 1.3 percent in purebred cats against 0.35 percent in mixed-breed cats, an odds ratio of 4.5 with a 95 percent confidence interval of 2.7 to 7.5 and p below 0.001. Six breeds showed a prevalence significantly greater than mixed-breed cats, being the Abyssinian, Bengal, Birman, Himalayan, Ragdoll and Rex, while the Burmese, Exotic Shorthair, Manx, Persian, Russian Blue and Siamese did not.

The individual breed numbers are where the caution belongs, and the breed cards above carry them one by one. The Birman's headline odds ratio of 82.06 is the highest in the study and its confidence interval of 26.66 to 262.44 nowhere near includes 1, so the effect is real in this dataset; it also rests on 4 affected cats out of 18 Birmans seen at a referral hospital, which is a small number drawn from a population already skewed towards sick animals. The Ragdoll figure rests on 2 cats out of 13 and the Bengal figure on a single cat out of 8.

Twenty-three breeds recorded zero FIP cases in the same 16 years, including 151 Maine Coons, 25 Balinese, 18 Tonkinese, 16 Ocicats and 15 Scottish Folds, and the authors state that the low background rate in the mixed-breed population prevented any calculation of significance or relative risk for those breeds. Zero cases in 151 cats is reassuring and is not the same as proof of protection.

What is not a breed effect

Three findings in that study are stronger than any breed result and apply to every cat in India. Sexually intact cats made up 45.6 percent of the FIP population against 15.8 percent of the general hospital population, with p below 0.001 for intact against altered animals. The median age at diagnosis was 0.96 years, with 67 percent of affected cats under two. And the majority of cases historically occur in multi-cat environments, with the highest prevalence in cats between three months and three years of age.

The sex finding is worth printing because it is often stated the other way round. More FIP cats in that series were male than female, 59.6 percent against 53.6 percent of the total cat population, but the difference was not statistically significant at p = 0.425. In the UK serological survey, sex, age and breed did not significantly affect neutralising antibody seroprevalence or titre against the type II virus either.

For an Indian buyer that ordering matters more than any breed table. The Persian is India's most commonly kept pedigree cat and it was not at significantly raised risk in the only study that ranked breeds, at 4 cases in 481 cats and p = 0.101. What raises risk in an Indian home is a young kitten bought from a crowded trader's setup, arriving unneutered, into a house that already has cats. Our guide to adopting a cat in India covers what a responsible source looks like, and cat sterilisation in India covers the operation that removes one of the four measured risk factors above.

One practical question follows from the Birman genetics work, and it is the question to ask a breeder. UC Davis studied 38 Birmans that died of FIP against 161 healthy Birmans and concluded that susceptibility has a genetic component in that breed. International Cat Care turns that into an instruction for breeding households: avoid breeding from queens or toms with a history of producing kittens that develop FIP, and never breed from a cat that has recovered from the disease. So ask whether any kitten from either parent, in any litter, has died of FIP, and treat an evasive answer as an answer.

What is different in India: one Chennai study, and everything that does not exist yet

India's FIP picture changed in 2026, and by exactly one paper. A team at Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, published the first molecular detection and genetic characterisation of feline coronavirus from India, screening 24 suspected feline cases from Chennai by RT-PCR against a 698 base-pair fragment of the spike gene. Before that, an Indian owner searching for Indian data on this disease found none.

What it found is worth printing exactly. Feline coronavirus was detected in 10 of the 24 cats, 41.7 percent, with a case fatality rate of 40 percent in that group. Read the denominator before reading the percentage: 24 suspected cases at one teaching hospital is a clinical caseload, not a survey of Indian cats, so 41.7 percent is a detection rate among animals already suspected of coronavirus disease and says nothing about how many Indian cats carry the virus.

The genetics carry the more interesting finding for anyone thinking about vaccines. The characterised Indian strain, designated FCoV/ABT/MVC/2024/001, showed 95.8 to 100 percent nucleotide identity with Asian and European isolates and 95.6 percent identity with canine coronavirus, and clustered phylogenetically with field isolates from China, Japan, Thailand, Italy, Australia and the USA while sitting apart from the Japanese vaccine strains. The authors identified nine major B-cell epitopes with conserved regions, alongside notable antigenic variability including extended epitopes and substitutions, which they read as antigenic drift that may reduce vaccine cross-protection.

Why Indian cat households are a good environment for this virus

Feline coronavirus needs cats sharing litter, and Indian urban cat keeping supplies that in quantity. Transmission is faecal to oral, most often when a cat grooms its paws after using a shared tray, and nearly every cat that meets the virus in a shedding cat's faeces becomes infected Taylor S, Tasker S, Barker E, Gunn-Moore D. Rescues, catteries and the multi-cat flats common in Indian cities are exactly the density at which antibody prevalence climbs above 80 percent.

Stress adds to it and India supplies that too. International Cat Care names a move to a new home, a stay in a boarding facility, a routine clinic visit, breeding and the introduction of a new cat as recognised risk-raising events, and the Indian clinic page ranking on this query adds overcrowding to the list of factors that may influence whether the mutation progresses to disease in one cat and not another. Hot, humid months in Indian cities push cats indoors together, which is a density problem even in a household that has not changed size. Our guide to indoor cat safety in India covers giving cats separate resources in a small flat, which is the practical version of this.

What the Cyprus outbreak means and does not mean for India

In late 2022 Cyprus experienced a large FIP epizootic caused by a recombinant virus named FCoV-23, whose spike region shows 96.5 percent sequence identity to a pantropic canine coronavirus, and which spread rapidly, infected cats of all ages and produced FIP unusually frequently. The field data are equally striking: across 68 veterinarian-reported cases from 22 Cypriot clinics, affected cats were older than FIP usually strikes at a mean of 3.9 years with a range of 0.4 to 12.9, and neurological or mental signs appeared in 35.3 percent.

That virus is not in India as far as anyone has published, and this page does not suggest it is. What the outbreak established is a mechanism worth knowing about: feline coronaviruses recombine, including across species with canine coronavirus, and a recombinant can behave very differently from the parent. The Chennai isolate's 95.6 percent identity with canine coronavirus sits in the same conversation, and India, with large free-ranging dog and cat populations in contact, is a place where more surveillance would be worth funding.

The vaccine question, which Google India asks directly, has a short answer in an Indian context. One licensed FIP vaccine exists internationally, its effectiveness at preventing FIP is questionable, and it is not routinely recommended by the American Association of Feline Practitioners' vaccine advisory panel. International Cat Care states that a vaccine was previously available and is not currently recommended. It is not part of the Indian core protocol, and our cat vaccination schedule for India covers what is.

Preventing FIP, which means preventing coronavirus load rather than preventing FIP

To reduce the risk of FIP, reduce how much feline coronavirus circulates in the house and how stressed the cats in it are, because the only way to definitively prevent FIP is to prevent coronavirus infection, and that is difficult given how ubiquitous the virus is. Nothing here is a guarantee. These measures lower the odds of a mutation happening in one of your cats, and they are the same measures that lower the odds of most other shared feline infections.

Litter management is the single lever with the clearest mechanism. The virus travels in faeces, so scoop daily, provide one tray per cat plus one spare, keep trays away from food and water bowls, and clean and disinfect trays, bowls and bedding regularly Taylor S, Tasker S, Barker E, Gunn-Moore D. Vetic's Indian clinic page makes the same list concrete for Indian flats, recommending clumping scoopable litter, daily scooping and separate trays for any new kitten.

Density is the second lever. Cornell recommends housing cats at or below three per room to minimise the stress associated with crowding, and International Cat Care advises keeping cats in small groups of fewer than five rather than many cats in one environment. For an Indian household the practical version is arithmetic about resources rather than floor area: enough trays, enough feeding stations, enough places to hide and to sit high.

1. Scoop every tray daily and keep one tray per cat plus one spare, because faecal-oral transfer is how this virus moves.
2. Separate litter from food and water, which Cornell names specifically.
3. Keep the group small, under five cats where possible, and give each cat its own resources.
4. Quarantine a new cat, which International Cat Care notes is suggested although the usefulness of the strategy is debated.
5. Reduce stress deliberately, with hiding places, vertical space and scratching posts, since recent stressful events are a recognised risk factor.
6. Keep other infections away, because preventing feline leukaemia virus and calicivirus with appropriate vaccination is likely to lower the chance of FIP developing.

What not to do, including one thing that sounds clever

Do not give antiviral drugs to healthy cats to stop them shedding coronavirus. International Cat Care states the reason directly: cats are rapidly reinfected, so the drug achieves little, and the practice may make antivirals less effective for treating FIP in future. The same guide says cats in contact with an affected cat should not be treated, because FIP is not transmitted from one cat to another and all of them have likely met the same coronaviruses already.

Do not buy a second cat to keep an affected or recovered cat company, at least not soon. International Cat Care advises waiting at least three months after a course finishes and introducing any new cat slowly, because introductions are a known stressor for a cat that is recovering. Where a household has already lost a cat to FIP, the advice on breeding is firmer still, which is never to breed from a cat that has recovered from the disease.

Breeding households carry a specific duty. Avoid breeding from queens or toms with a history of producing kittens that go on to develop FIP, which is the practical translation of the Birman genetics work showing a heritable component to susceptibility. For an Indian buyer, that is the question to put to a breeder before any money moves, and our guide on adopting a cat in India sets out the rest of the checklist.

Living with it: the twelve weeks, the other cats, and the people in the house

To get a cat through FIP treatment, do four things, which are to weigh it at least weekly, to give every dose on schedule for the full course, to keep a written record of appetite, weight and signs, and to go back to the veterinarian if it is not visibly better within three to five days. The reason to weigh weekly is not curiosity. A growing or recovering cat gains weight, and the amount of medicine has to keep pace with it, which is a calculation for the veterinarian and not for a chart on a sales page.

Giving medicine daily to a cat for twelve weeks is the part owners underestimate. International Cat Care's practical list is worth following: try both tablets and liquid to see which the cat accepts, hide the dose in a small treat rather than in a main meal so you can see it has gone down, remove food briefly beforehand so the cat is hungry, pair dosing with something the cat enjoys, and ask for an appetite stimulant if a poorly cat will not take treats. Owners who struggle should call the clinic early rather than skipping doses.

Expect side effects to be minor and expect the injectable route to hurt. Changes in liver enzymes and white cell counts are the usual findings and generally need no treatment or interruption. Remdesivir and GS-441524 are acidic and cause pain when injected under the skin, which is why that route is not recommended unless it is the only option, and why injection pain was the commonest side effect in the 307-cat cohort at 47.8 percent of cats given subcutaneous remdesivir. Urinary stones made of the drug itself have occasionally been reported, so straining to urinate or blood in the urine during treatment is a reason to call the vet.

Your other cats, and you

FIP does not pass from cat to cat, and it does not pass to people. International Cat Care states that FIP is not transmitted from one cat to another and that cats without FIP should not be treated with antivirals. Cornell states that to its knowledge coronaviruses cannot be passed from infected cats to humans. What does move between cats is the ordinary enteric coronavirus, which the other cats in the house have almost certainly already met.

That is why isolating the affected cat is about comfort rather than containment. A very unwell cat may do better in a smaller quiet space away from the others, and can rejoin them when it feels better. The litter-tray arithmetic still applies to the household as a whole, one tray per cat plus one, cleaned daily.

After the course, and what the long-term data now shows

Neutering and vaccination both wait. Neutering is ideally performed a month or more after treatment finishes, although it can be done towards the end of the course if the cat is well, and routine vaccination is ideally given about a month after completion so that a mild vaccine reaction is not mistaken for a relapse. Worming and flea treatment, by contrast, carry on as normal, and our cat deworming schedule for India covers the timing.

Monitoring continues past the last dose. Test results should be normal before the antiviral is stopped, and the Indian clinic page describes an observation period of 8 to 12 weeks after treatment during which weight, appetite, activity and blood parameters are tracked, with cats that stay symptom-free through it considered cured. That observation window is why a seller's 84-day protocol is not the whole commitment.

Two long-term findings are new enough that most pages on this topic do not carry them, and an owner deserves both. Four cats out of a 202-cat treatment cohort, 2.0 percent, developed large-cell lymphoma between 81 and 595 days after FIP diagnosis and successful treatment, an incidence the authors call remarkably high against the general cat population and propose considering as a possible long-FIP syndrome. Separately, a small case series describes progressive hydrocephalus appearing more than a year after successful treatment of neurological FIP, which the authors stress must be told apart from a relapse because the treatment differs. Neither finding argues against treating. Both argue for a check-up after the course rather than closing the file.

FIP is not the only infection an Indian cat meets in a crowded household, and the others have their own pages here. Feline panleukopenia is the vaccine-preventable one that kills kittens fastest, and rabies in dogs and cats in India is the one with a public health dimension and a legal framework behind it. FIP is the one where the decisive act is a correct diagnosis before a long and expensive course begins.